Pay in 4 interest-free payments of $22.88 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Hydroxyfasudil also significantly decreases the maximal detrusor pressure
Chemical Name: [5-[5-[5-(hydroxymethyl)thiophen-2-yl]furan-2-yl]thiophen-2-yl]methanol
InChi: InChI=1S/C13H8O3/c14-8-5-6-10-9-3-1-2-4-11(9)13(15)16-12(10)7-8/h1-7
InChi: InChI=1S/C20H24ClN3O4S
NVP-ACC789 which is given in daily oral doses for 6 days blocks VEGF-induced angiogenesis in a dose-dependent manner
Sitagliptin phosphate ine(Oxedrine) Hydroxyfasudil also significantly decreases theSitagliptin (INN; previously identified as MK 0431 and sold under the trade name Januvia) is an oral antihyperglycemic (anti diabetic drug) of the dipeptidyl peptidase 4 (DPP 4) inhibitor class. It was developed and is marketed by Merck & Co. This enzyme inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of
US$ 589.50
US$ 629.50
US$ 18.00
US$ 414.00
US$ 108.00
US$ 513.50
US$ 646.00
US$ 977.50
US$ 745.50
US$ 111.00
US$ 388.50
US$ 102.50
US$ 712.50
US$ 433.50
US$ 2471.50
US$ 712.50